• Ocean Man
    The FTC approved Teva's acquisition of Cephalon. This means a spot in the S&P 500 is opening up. Who gets it? I'm hoping for NYCB. GMCR? LVS?
    10/8/11
    Reply (2)
    • Brandon Gibbs: NYCB is a favorite of mine, priced nicely as of late. Where does price go in the event of getting the s&p spot? $15/16?
      10/8/11
    • Ocean Man: Probably good for a 10% bump. Maybe more for the smaller cap additions. $15.50 would be huge although only halfway back to its 52-week high.
      10/8/11